A Review of Treatments for HFrEF and Expert Q&A
Despite substantial advances in therapeutic options for HFrEF, significant gaps remain in the use of guideline-directed medical therapy in these patients.
Despite substantial advances in therapeutic options for HFrEF, significant gaps remain in the use of guideline-directed medical therapy in these patients.
Chronic hypertension in pregnant women emerged as the strongest predictor of preterm delivery prior to 34 weeks’ gestation in a retrospective study conducted in the UK.
Risk for heart failure hospitalization in postmenopausal women increased with sitting, sedentary behavior
A new study compared the effects of renin-angiotensin-system inhibitor and calcium channel blocker therapy on the risks for kidney replacement therapy, major cardiovascular events, and death among patients with advanced CKD.
Adherence to diuretic therapy decreases as lower urinary tract symptoms increase in severity, according to a new study.
Higher proportion of physician visits included hypertension for adults living in rural, small-medium metro areas.
This accounts for about a quarter of the total effect on blood pressure control.
Sotagliflozin might help patients with diabetes and chronic kidney disease who are hospitalized with heart failure avoid a readmission, study results suggest.
Reduction comparable to adherence to Mediterranean diet or moderate reduction in salt.
New findings could allow clinicians to have more nuanced discussions with patients who have chronic kidney disease regarding the long-term risks associated with alpha blocker use to control blood pressure.